ロード中...
Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
The coronavirus (CoV) disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome CoV-2 (SARS-CoV-2) is a health threat worldwide. Viral main protease (M(pro), also called 3C‐like protease [3CL(pro)]) is a therapeutic target for drug discovery. Herein, we report that GC376, a broad-...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7449189/ https://ncbi.nlm.nih.gov/pubmed/32669265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00872-20 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|